Aemetis, Inc. (NASDAQ:AMTX) Files An 8-K Results of Operations and Financial Condition

Aemetis, Inc. (NASDAQ:AMTX) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

Story continues below

On November 9, 2017, Aemetis, Inc. (the “Company”) issued a press release announcing its earnings for the three and nine months ended September 30, 2017.

The press release is being furnished as Exhibit99.1 to this Current Report on Form8-K and is incorporated herein by reference.

This Form8-K and Exhibits 99.1 hereto shall be deemed “furnished” and not “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any registration statement of the issuer.

Item 7.01 Regulation FD Material.

On November 9, 2017, the Company issued a news release, posted to its web site at www.aemetis.com, announcing its earnings for the three and nine months ended September 30, 2017, a copy of which is filed as Exhibit 99.1 hereto and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

EXHIBITNUMBER

DESCRIPTION

Exhibit 99.1

Earnings Release dated November 9, 2017


AEMETIS, INC Exhibit
EX-99.1 2 amtx_ex991.htm PRESS RELEASE Blueprint   Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected]     Investor Relations & Media Contact: Satya Chillara (408) 213-0939 [email protected]   Aemetis,…
To view the full exhibit click here

About Aemetis, Inc. (NASDAQ:AMTX)

Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company’s approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company’s over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.

An ad to help with our costs